ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

UNC Oncologist Edison Liu To Direct NCI Intramural Clinical Research Programs

June 28, 1996

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

In Brief: $7 Mil. Gift allows USC To Expand Gene Therapy; North Carolina Passes Off-Label Drug Legislation

September 3, 1993

CCOP Review Completed; 72 Applications Submitted, 23 More For Minority CCOP

December 1, 1989

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

New Atlas Showing nonwhite Mortality Rates Available

January 7, 1977